Xiu Zhou

468 total citations
19 papers, 390 citations indexed

About

Xiu Zhou is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Xiu Zhou has authored 19 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 11 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Molecular Biology. Recurrent topics in Xiu Zhou's work include Diet, Metabolism, and Disease (10 papers), Liver Disease Diagnosis and Treatment (9 papers) and Metabolism, Diabetes, and Cancer (4 papers). Xiu Zhou is often cited by papers focused on Diet, Metabolism, and Disease (10 papers), Liver Disease Diagnosis and Treatment (9 papers) and Metabolism, Diabetes, and Cancer (4 papers). Xiu Zhou collaborates with scholars based in Australia, China and United States. Xiu Zhou's co-authors include Ji‐Ming Ye, Xiao‐Yi Zeng, Hao Wang, Songpei Li, Dongli Li, Juan Carlos Molero, Ruo‐Qiong Sun, Charlie Changli Xue, Stanley M. H. Chan and Stephen R. Robinson and has published in prestigious journals such as PLoS ONE, Endocrinology and British Journal of Pharmacology.

In The Last Decade

Xiu Zhou

19 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiu Zhou Australia 13 181 171 102 86 67 19 390
Qing Song China 11 170 0.9× 258 1.5× 68 0.7× 96 1.1× 69 1.0× 27 445
Xu-Jun Qin China 6 205 1.1× 158 0.9× 76 0.7× 109 1.3× 36 0.5× 8 441
Marijke Schreurs Netherlands 9 202 1.1× 156 0.9× 102 1.0× 142 1.7× 38 0.6× 12 448
Yunxia Lu China 12 141 0.8× 91 0.5× 63 0.6× 88 1.0× 54 0.8× 29 344
Helena Daňková Czechia 14 202 1.1× 235 1.4× 73 0.7× 155 1.8× 31 0.5× 23 598
Wen Shan China 10 229 1.3× 205 1.2× 63 0.6× 89 1.0× 27 0.4× 13 508
Flávia Maria Silva-Veiga Brazil 12 198 1.1× 191 1.1× 87 0.9× 231 2.7× 47 0.7× 23 435
Shudong Liu China 10 273 1.5× 130 0.8× 98 1.0× 87 1.0× 24 0.4× 21 522

Countries citing papers authored by Xiu Zhou

Since Specialization
Citations

This map shows the geographic impact of Xiu Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiu Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiu Zhou more than expected).

Fields of papers citing papers by Xiu Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiu Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiu Zhou. The network helps show where Xiu Zhou may publish in the future.

Co-authorship network of co-authors of Xiu Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Xiu Zhou. A scholar is included among the top collaborators of Xiu Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiu Zhou. Xiu Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Li, Bing, Weiming Fang, Xiu Zhou, et al.. (2024). Oral matrine alleviates CCl4-induced liver fibrosis via preserved HSP72 from modulated gut microbiota. Biomedicine & Pharmacotherapy. 178. 117262–117262. 4 indexed citations
2.
Cai, Bing, et al.. (2023). The dynamic expression of SOX17 in germ cells from human female foetus and adult ovaries after specification. Frontiers in Endocrinology. 14. 1124143–1124143. 3 indexed citations
3.
Hou, Ya‐Jun, Xuan Zhao, Yalin Wang, et al.. (2023). Oleuropein-Rich Jasminum Grandiflorum Flower Extract Regulates the LKB1-PGC-1α Axis Related to the Attenuation of Hepatocellular Lipid Dysmetabolism. Nutrients. 16(1). 58–58. 2 indexed citations
4.
Li, Chan, Yao‐Hao Xu, Yu‐Tao Hu, et al.. (2022). Matrine counteracts obesity in mice via inducing adipose thermogenesis by activating HSF1/PGC-1α axis. Pharmacological Research. 177. 106136–106136. 16 indexed citations
5.
Wang, Yalin, Xiu Zhou, Dongli Li, & Ji‐Ming Ye. (2021). Role of the mTOR-autophagy-ER stress pathway in high fructose-induced metabolic-associated fatty liver disease. Acta Pharmacologica Sinica. 43(1). 10–14. 23 indexed citations
6.
Chan, Stanley M. H., et al.. (2021). Exposure to cigarette smoke precipitates simple hepatosteatosis to NASH in high-fat diet fed mice by inducing oxidative stress. Clinical Science. 135(17). 2103–2119. 8 indexed citations
7.
Zhou, Xiu, et al.. (2020). Involvement of the Autophagy-ER Stress Axis in High Fat/Carbohydrate Diet-Induced Nonalcoholic Fatty Liver Disease. Nutrients. 12(9). 2626–2626. 21 indexed citations
8.
Chan, Stanley M. H., et al.. (2020). Cigarette smoking blocks the benefit from reduced weight gain for insulin action by shifting lipids deposition to muscle. Clinical Science. 134(13). 1659–1673. 4 indexed citations
9.
Zhou, Xiu, Xiao‐Yi Zeng, Dongli Li, et al.. (2019). Characterization of the Therapeutic Profile of Albiflorin for the Metabolic Syndrome. Frontiers in Pharmacology. 10. 1151–1151. 17 indexed citations
10.
Li, Songpei, Xiu Zhou, Dongli Li, et al.. (2019). Matrine Protects Against MCD-Induced Development of NASH via Upregulating HSP72 and Downregulating mTOR in a Manner Distinctive From Metformin. Frontiers in Pharmacology. 10. 405–405. 30 indexed citations
11.
Zeng, Xiao‐Yi, Xiu Zhou, Songpei Li, et al.. (2018). Repurposing matrine for the treatment of hepatosteatosis and associated disorders in glucose homeostasis in mice. Acta Pharmacologica Sinica. 39(11). 1753–1759. 17 indexed citations
12.
13.
Chan, Stanley M. H., Xiao‐Yi Zeng, Ruo‐Qiong Sun, et al.. (2015). Fenofibrate insulates diacylglycerol in lipid droplet/ER and preserves insulin signaling transduction in the liver of high fat fed mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1852(7). 1511–1519. 24 indexed citations
14.
Li, Songpei, Xiao‐Yi Zeng, Xiu Zhou, et al.. (2015). Dietary cholesterol induces hepatic inflammation and blunts mitochondrial function in the liver of high-fat-fed mice. The Journal of Nutritional Biochemistry. 27. 96–103. 26 indexed citations
15.
Zhou, Xiu, Jun Xu, Yuguang Shi, & Ji-Ming Ye. (2015). Discovery of Novel Anti-Diabetic Drugs by Targeting Lipid Metabolism. Current Drug Targets. 16(12). 1372–1380. 14 indexed citations
16.
Zeng, Xiao‐Yi, Hao Wang, Fang Bai, et al.. (2015). Identification of matrine as a promising novel drug for hepatic steatosis and glucose intolerance with HSP72 as an upstream target. British Journal of Pharmacology. 172(17). 4303–4318. 62 indexed citations
17.
Wang, Hao, Ruo‐Qiong Sun, Xiao‐Yi Zeng, et al.. (2014). Restoration of Autophagy Alleviates Hepatic ER Stress and Impaired Insulin Signalling Transduction in High Fructose-Fed Male Mice. Endocrinology. 156(1). 169–181. 55 indexed citations
18.
Zhou, Xiu, Xiao‐Yi Zeng, Hao Wang, et al.. (2014). Hepatic FoxO1 Acetylation Is Involved in Oleanolic Acid-Induced Memory of Glycemic Control: Novel Findings from Study 2. PLoS ONE. 9(9). e107231–e107231. 21 indexed citations
19.
Zeng, Xiao‐Yi, Xiu Zhou, Jun Xu, et al.. (2012). Screening for the efficacy on lipid accumulation in 3T3-L1 cells is an effective tool for the identification of new anti-diabetic compounds. Biochemical Pharmacology. 84(6). 830–837. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qing Song Breakdown of academic impact, for papers by Xu-Jun Qin Breakdown of academic impact, for papers by Marijke Schreurs Breakdown of academic impact, for papers by Yunxia Lu Breakdown of academic impact, for papers by Helena Daňková Breakdown of academic impact, for papers by Wen Shan Breakdown of academic impact, for papers by Flávia Maria Silva-Veiga Breakdown of academic impact, for papers by Shudong Liu
Rankless by CCL
2026